Monday, August 3, 2020

SII gets nod for Oxford Covid-19 vaccine candidate's Phase 2 and 3 human trials

 The approval to SII was granted by Dr VG Somani late on Sunday after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

Posted from: this blog via Microsoft Flow.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)